Benralizumab Effectiveness in EGPA | MicrobiomeTrials← Back to trialsNCT07815886
Benralizumab Effectiveness in EGPA
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-02-11Est. Completion: 2027-02-11
Enrollment target: 100 participants Locations- Edoardo Biancalana, Florence, Italy, Italy
Other microbiome trials you might be interested in
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)
This observational study aims to evaluate the long-term effectiveness and safety of mepolizumab 300 mg/4 weeks in adults…
Florence, ItalyCompleted Mar 31, 2026
Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss Syndrome
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive n…
San Diego, United StatesEst. completion Dec 2028